Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. articles
  3. diagnostic biomarker development
Show results for
Articles

Refine by
Date

  • Older

Diagnostic Biomarker Development Articles & Analysis: Older

22 articles found

Understanding Synthetic Peptides: A Gateway to Advanced Biotechnological Applications

Understanding Synthetic Peptides: A Gateway to Advanced Biotechnological Applications

In the rapidly evolving world of biotechnology, synthetic peptides have emerged as a pivotal component with wide-ranging applications in medical research, diagnostics, and therapeutic developments. These lab-created sequences of amino acids mimic naturally occurring peptides and are instrumental in advancing scientific discoveries and pharmaceutical innovations. This article delves into the ...

ByCreative Enzymes


Alfa Cytology Announces Cancer Diagnostic Biomarker Development Services to Enhance Precision in Oncology Research

Alfa Cytology Announces Cancer Diagnostic Biomarker Development Services to Enhance Precision in Oncology Research

Alfa Cytology has announced cancer diagnostic biomarker development services to enhance precision in oncology research. Alfa Cytology, a pioneering biotech firm comprising an interdisciplinary team of scientists, bioinformaticians, and oncologists, has recently introduced its cancer diagnostic biomarker ...

ByAlfa Cytology


 Advances in Cytoskeletal Research

Advances in Cytoskeletal Research

When we look at the awe-inspiring architecture of life at the cellular level, one of the most intriguing and essential features is the cytoskeleton. This dynamic network of protein filaments provides structure, facilitates movement, and enables intracellular transport. Advances in technology have revolutionized our understanding of the cytoskeleton and have expanded the possibilities of ...

ByCDBioSciences - VLPlant


Nano Antibody Sequencing

Nano Antibody Sequencing

When we talk about antibody sequencing, we often think of issues related to disease treatment and improving human health. Nanobody sequencing provides us with a more precise and efficient solution. Nanobodies, also known as single-domain antibodies, are antibodies composed of a single functional domain. They have the advantages of small size, high stability, and good penetration, and therefore ...

ByMtoZ Biolabs


   Harnessing the Power of the Immune System: The Rise of Cancer Vaccines in Oncology

Harnessing the Power of the Immune System: The Rise of Cancer Vaccines in Oncology

Cancer is a daunting diagnosis; however, the rapid advancements in oncology are continuously perfecting patient outcomes and quality of life. Among the groundbreaking developments, cancer vaccines are a promising frontier1. These vaccines are transforming how we approach cancer treatment, leveraging the body's immune system to fight malignancies more effectively. ...

ByAlfa Cytology


Application of Lipidomics in the Pharmaceutical Research

Application of Lipidomics in the Pharmaceutical Research

Identification of key lipids and related enzymes can help to identify potential abnormalities in metabolic pathways or pathogenic mechanisms, and eventually develop effective diagnostic and therapeutic tools. Depending on the focus of the study, lipidomics can be applied to the following pharmaceutical research. ...

ByCreative Proteomics


Cytokine Profiling in Oncology: The Power of Luminex Technology   

Cytokine Profiling in Oncology: The Power of Luminex Technology  

By analyzing the levels of cytokines before and after treatment, researchers can gain insight into the effectiveness of cancer therapies and the potential for immunotherapy. Identification of biomarkers Luminex technology is also being used to identify new biomarkers for cancer. By profiling cytokine levels in cancer patients, researchers are able to identify ...

ByCreative Proteomics


The Role of Cytokine Profiling in Oncology Research

The Role of Cytokine Profiling in Oncology Research

By analyzing the levels of cytokines before and after treatment, researchers can gain insight into the effectiveness of cancer therapies and the potential for immunotherapy. Identification of biomarkers Luminex technology is also being used to identify new biomarkers for cancer. By profiling cytokine levels in cancer patients, researchers are able to identify ...

ByCreative Proteomics


Rare Disease Research: from Diagnostic Development to Small Molecule Drug Development

Rare Disease Research: from Diagnostic Development to Small Molecule Drug Development

Rare diseases, also known as orphan diseases, affect a small percentage of the population, making them particularly challenging to diagnose and treat. However, thanks to advancements in medical research and technology, significant progress has been made in the field of rare disease research, from developing accurate diagnostic tools to making effective small-molecule drugs. One of the biggest ...

ByProtheragen


Karyotype Analysis for Rare Disease

Karyotype Analysis for Rare Disease

Karyotype analysis refers to the pairing and grouping of chromosomes to reveal whether the organism accords with the inherent chromosomal characteristics, to determine if the organism has chromosomal abnormalities. Karyotype analysis can detect whether there are abnormalities in chromatin length, centromere position, the ratio of long and short arms, and the presence or absence of satellites. ...

ByProtheragen


Innovative Diagnostic Development Urges Rare Disease Therapies

Innovative Diagnostic Development Urges Rare Disease Therapies

These diseases often come with significant challenges, including accurate diagnosis, availability of effective treatments, and limited resources for research and development. However, recent advancements in diagnostics technology hold promise for speeding up the field of rare disease therapies. ...

ByProtheragen


Breaking Barriers – Past and Current: Celebrating the Legacy of Dr. Clarice Reid, Pioneer in Sickle Cell Research, Biomark Diagnostics

Breaking Barriers – Past and Current: Celebrating the Legacy of Dr. Clarice Reid, Pioneer in Sickle Cell Research, Biomark Diagnostics

Clarice Reid, a true leader and advocate for those affected by sickle cell disease and BioMark Diagnostics Inc. a diagnostic company focused in developing better cancer care management solutions. ...

ByBioMark Diagnostics Inc.


Case Study B - Liquid Biopsy

Case Study B - Liquid Biopsy

X-ZELL is collaborating with Singapore General Hospital (SGH) and the National University Hospital Singapore (NUH) to explore how X-ZELL single-cell diagnostics may aid in the early detection of clinically significant prostate cancer in whole blood. The prospectively blinded, 400-patient multi-centre study officially commenced in 2020 and will lay the foundation for the launch of a commercially ...

ByX-Zell Inc.


Carrie Fisher: Bipolar Disorder

Carrie Fisher: Bipolar Disorder

Carrie Fisher was an American actress most well known for her role as Princess Leia in the Star Wars films (1977-1983 and 2015-2019). She was the daughter of singer Eddie Fisher and actress Debbie Reynolds. Carrie Fisher wrote the semi-autobiographical book Postcards from the Edge and the autobiography Wishful Drinking, which she turned into a one-woman stage show. She was open throughout her ...

ByBioSerenity


Carrie Fisher: Bipolar Disorder

Carrie Fisher: Bipolar Disorder

How can BioSerenity help with the diagnosis of bipolar disorder? BioSerenity is developing remote diagnostics and physiologic signal recording to help in the detection of depression, bipolar disorder, and schizophrenia. Our goal is to provide a portable, ambulatory diagnostic device to allow screening and biomarker analysis of ...

ByBioSerenity


AIM movers: Positive erectile dysfunction news from Futura and Shoe Zone continues to surprise

AIM movers: Positive erectile dysfunction news from Futura and Shoe Zone continues to surprise

Futura Medical (LON: FUM) says that the clinical study for the MED3000 topical gel erectile dysfunction treatment has met its primary and secondary endpoints. They showed an improvement in erectile function and a highly statistic improvement in the onset of action at 10 minutes. There were limited side effects with 4.3% of patient suffering headaches and a further 4.3% nausea, which is much ...

ByFutura Medical


INOVIQ study validates the use of SubB2M as an aid in diagnosing malignant melanoma

INOVIQ study validates the use of SubB2M as an aid in diagnosing malignant melanoma

“Importantly, the detection of Neu5Gc in these cancer tissues is consistent with its role as a pan-cancer biomarker and further supports the development of INOVIQ’s SubB2M-based blood tests for breast and ovarian ...

ByINOVIQ Ltd


Developing Research and Medical Diagnostic Products

Developing Research and Medical Diagnostic Products

The demand for research and MEDICAL DIAGNOSTIC products grows annually. Because medical diagnostic devices are used in the testing, treatment, prevention, monitoring, studying, and diagnosis of diseases and other biological human conditions, companies that develop and manufacture such diagnostic products are well positioned to serve an important and vital role in health and healthcare, the ...

ByBMP Medical


Universal Diagnostics Initiates Observational Study in the US to Evaluate Cell Free DNA Blood Test for Adenomas and Colorectal Cancer

Universal Diagnostics Initiates Observational Study in the US to Evaluate Cell Free DNA Blood Test for Adenomas and Colorectal Cancer

SEVILLE, Spain--(BUSINESS WIRE)--Universal Diagnostics (UDX), an in-vitro diagnostics company developing minimally-invasive, blood-based solutions for detecting cancer early, announced today that it has started a prospective, multi-center observational study in the US for its investigational advanced adenoma (precursor lesions) and colorectal ...

ByUniversal Diagnostics SL


Combination of two epitope identification techniques enables the rational design of soy allergen Gly m 4 mutants

Combination of two epitope identification techniques enables the rational design of soy allergen Gly m 4 mutants

Abstract Detailed IgE-binding epitope analysis is a key requirement for the understanding and development of diagnostic and therapeutic agents to address food allergies. An IgE-specific linear peptide microarray with random phage peptide display for the high-resolution mapping of IgE-binding epitopes of the major soybean allergen Gly m 4, which is a homologue to the birch pollen allergen Bet v ...

ByLenioBio GmbH

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Industry Products
  • Medical Industry Software
  • Medical Industry Training
  • Medical Industry Services
  • Medical Industry Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles
  • Medical Industry Books
  • Medical Industry Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT